國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Leading pharmaceutical innovationhow...

Gassmann, Oliver.

Leading pharmaceutical innovationhow to win the life science race /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Leading pharmaceutical innovationby Oliver Gassmann ... [et al.].
其他題名:	how to win the life science race /
其他作者:	Gassmann, Oliver.
出版者:	Cham :Springer International Publishing :2018.
面頁冊數:	xv, 179 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Pharmaceutical industryTechnological innovations.
電子資源:	http://dx.doi.org/10.1007/978-3-319-66833-8
ISBN:	9783319668338$q(electronic bk.)

Leading pharmaceutical innovationhow to win the life science race /
Leading pharmaceutical innovationhow to win the life science race /[electronic resource] :by Oliver Gassmann ... [et al.]. - 3rd ed. - Cham :Springer International Publishing :2018. - xv, 179 p. :ill., digital ;24 cm.

Innovation: Key to Success in the Pharmaceutical Industry -- The Industry Challenge: Who Would Want to Be in This Business?- The Science and Technology Challenge: How to Find New Drugs -- The Pipeline Challenge: How to Organize Innovation -- The Make-or-Buy Challenge: How to In- and Outsource Innovation -- The Open Innovation Challenge: How to Partner for Innovation -- The Internationalization Challenge: Where to Access Innovation -- Future Directions and Trends.

This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation. Health care innovation is possibly the greatest opportunity and challenge of our generation. This important book shows how pharmaceutical companies will continue to play an instrument role in making our lives better. Stefan Thomke, William Barclay Harding Professor of Business Administration, Harvard Business School Very comprehensive review and analysis of current challenges for the biopharmaceutical industry. To stay competitive in this new technology driven environment, the industry started to develop new partnership models to close the innovation gap and provide patients with the relevant healthcare toolkits at the convergence of pharmaceuticals, diagnostics and IT technologies. Very exciting times ahead well depicted in this book! Karima Boubekeur, VP Emerging Portfolio and Search & Evaluation, AstraZeneca Great. The 3rd edition is not only an update. It's an outstandingly featured summary on the challenges of pharma innovation. Eckard von Keutz, SVP and Head of Early Development, Bayer Healthcare.

ISBN: 9783319668338$q(electronic bk.)

Standard No.: 10.1007/978-3-319-66833-8doiSubjects--Topical Terms:

276225
Pharmaceutical industry
--Technological innovations.

LC Class. No.: HD9665.5

Dewey Class. No.: 338.476151

Leading pharmaceutical innovationhow to win the life science race /
LDR:03369nmm a2200337 a 4500 001 538552
003 DE-He213
005 20181116161401.0
006 m d
007 cr nn 008maaau
008 190122s2018 gw s 0 eng d
020 $a 9783319668338$q(electronic bk.)
020 $a 9783319668321$q(paper)
024 7 $a 10.1007/978-3-319-66833-8 $2 doi
035 $a 978-3-319-66833-8
040 $a GP $c GP
041 0 $a eng
050 4 $a HD9665.5
072 7 $a KJMV6 $2 bicssc
072 7 $a PDG $2 bicssc
072 7 $a BUS087000 $2 bisacsh
082 0 4 $a 338.476151 $2 23
090 $a HD9665.5 $b .L434 2018
245 0 0 $a Leading pharmaceutical innovation $h [electronic resource] : $b how to win the life science race / $c by Oliver Gassmann ... [et al.].
250 $a 3rd ed.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a xv, 179 p. : $b ill., digital ; $c 24 cm.
505 0 $a Innovation: Key to Success in the Pharmaceutical Industry -- The Industry Challenge: Who Would Want to Be in This Business?- The Science and Technology Challenge: How to Find New Drugs -- The Pipeline Challenge: How to Organize Innovation -- The Make-or-Buy Challenge: How to In- and Outsource Innovation -- The Open Innovation Challenge: How to Partner for Innovation -- The Internationalization Challenge: Where to Access Innovation -- Future Directions and Trends.
520 $a This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation. Health care innovation is possibly the greatest opportunity and challenge of our generation. This important book shows how pharmaceutical companies will continue to play an instrument role in making our lives better. Stefan Thomke, William Barclay Harding Professor of Business Administration, Harvard Business School Very comprehensive review and analysis of current challenges for the biopharmaceutical industry. To stay competitive in this new technology driven environment, the industry started to develop new partnership models to close the innovation gap and provide patients with the relevant healthcare toolkits at the convergence of pharmaceuticals, diagnostics and IT technologies. Very exciting times ahead well depicted in this book! Karima Boubekeur, VP Emerging Portfolio and Search & Evaluation, AstraZeneca Great. The 3rd edition is not only an update. It's an outstandingly featured summary on the challenges of pharma innovation. Eckard von Keutz, SVP and Head of Early Development, Bayer Healthcare.
650 0 $a Pharmaceutical industry $x Technological innovations. $3 276225
650 0 $a Pharmaceutical industry $x Technological innovations $v Case studies. $3 815644
650 0 $a Drugs $x Research $x Management. $3 276226
650 0 $a Drugs $x Research $x Management $v Case studies. $3 815645
650 1 4 $a Business and Management. $2 eflch $3 639169
650 2 4 $a Innovation/Technology Management. $3 514149
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Pharmacoeconomics and Health Outcomes. $3 696758
650 2 4 $a Pharmacy. $3 218145
650 2 4 $a Health Care Management. $3 674996
650 2 4 $a Health Economics. $3 522380
700 1 $a Gassmann, Oliver. $3 276224
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-66833-8
950 $a Business and Management (Springer-41169)